| Prelude Fertility | 71.7 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 71.7 | 3 | 1 |
| Colorado Center for Reproductive Medicine | 61.0 | 2 | 1 |
| Sher Fertility | 61.0 | 2 | 1 |
| Mayo Clinic | 60.0 | 4 | 0 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Pacific Fertility Center | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| American Society for Reproductive Medicine | 45.8 | 1 | 1 |
| Seattle Reproductive Medicine | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New York | 45.8 | 1 | 1 |
| Reproductive Medicine Institute | 45.8 | 1 | 1 |
| Massachusetts General Hospital | 41.0 | 2 | 0 |
| Newsweek | 41.0 | 2 | 0 |
| Epi Info | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| UCLA Health System | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| Fertility Center of San Antonio | 41.0 | 2 | 0 |
| San Diego Fertility Center | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| Shady Grove Fertility Center | 41.0 | 2 | 0 |
| Cooper Health System | 41.0 | 2 | 0 |
| UH Cleveland Medical Center | 41.0 | 2 | 0 |
| Fertility Centers of Illinois | 41.0 | 2 | 0 |
| New Hope Fertility Center | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| Christopher R. Conley | 41.0 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 41.0 | 2 | 0 |
| Stanford Children's Health | 41.0 | 2 | 0 |
| Healthcare Infection Control Practices Advisory Committee | 41.0 | 2 | 0 |
| Progyny, Inc. | 41.0 | 2 | 0 |
| fertility clinic | 40.0 | 0 | 3 |
| Fertility and Sterility | 40.0 | 0 | 3 |
| Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates | 40.0 | 0 | 3 |
| Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study | 40.0 | 0 | 3 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 40.0 | 0 | 3 |
| Corrigendum: Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 40.0 | 0 | 3 |
| Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study | 40.0 | 0 | 3 |
| Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer | 40.0 | 0 | 3 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 40.0 | 0 | 3 |
| Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial | 40.0 | 0 | 3 |
| P–090 Cumulative live birth rates (CLBR) per embryo transfer, embryo transferred and inseminated oocyte are not affected by paternal age in infertile male donor egg cycles | 40.0 | 0 | 3 |
| assisted reproductive technology | 31.7 | 0 | 2 |
| egg donation | 31.7 | 0 | 2 |
| preimplantation genetic diagnosis | 31.7 | 0 | 2 |
| third-party reproduction | 31.7 | 0 | 2 |
| Reproductive Medicine and Biology | 31.7 | 0 | 2 |
| Naprotechnology | 31.7 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 31.7 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 31.7 | 0 | 2 |
| Methods for endometrial preparation in frozen-thawed embryo transfer cycles | 31.7 | 0 | 2 |
| Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature | 31.7 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 31.7 | 0 | 2 |
| A two- versus three-embryo transfer: the oocyte donation model | 31.7 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 31.7 | 0 | 2 |
| Treatment decision making in anonymous donor egg in-vitro fertilisation: a qualitative study of childless women and women with genetically related children. | 31.7 | 0 | 2 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 31.7 | 0 | 2 |
| Oocyte donation in infertility treatment--a review | 31.7 | 0 | 2 |
| Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? | 31.7 | 0 | 2 |
| Monozygotic twins with discordant karyotypes following preimplantation genetic screening and single embryo transfer: case report | 31.7 | 0 | 2 |
| Primary ovarian pregnancy after donor embryo transfer: early diagnosis and laparoscopic treatment. | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 31.7 | 0 | 2 |
| Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Donor egg IVF model to assess ecological implications for ART success | 31.7 | 0 | 2 |
| Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses | 31.7 | 0 | 2 |
| Preimplantation genetic screening of blastocysts by multiplex qPCR followed by fresh embryo transfer: validation and verification | 31.7 | 0 | 2 |
| Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles | 31.7 | 0 | 2 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 31.7 | 0 | 2 |
| Gonadotropin-releasing hormone agonist for oocyte triggering in endometrial preparation of letrozole stimulation protocols does not affect clinical outcome of frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 31.7 | 0 | 2 |
| Optimizing natural fertility | 31.7 | 0 | 2 |
| Repetitive oocyte donation | 31.7 | 0 | 2 |
| Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles | 31.7 | 0 | 2 |
| Effect of Natural Cycle Endometrial Preparation for Frozen-Thawed Embryo Transfer in Patients with Advanced Endometriosis. | 31.7 | 0 | 2 |
| Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial | 31.7 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Multiple births from fertility treatment in the UK: A Consensus statement | 31.7 | 0 | 2 |
| Elective single-embryo transfer | 31.7 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 31.7 | 0 | 2 |
| Cryopreserved Embryo Transfer: Endometrial Preparation and Timing | 31.7 | 0 | 2 |
| Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity | 31.7 | 0 | 2 |
| Does a vitrified blastocyst stage embryo transfer program need hormonal priming for endometrial preparation? | 31.7 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 31.7 | 0 | 2 |
| Comprehensive chromosome screening improves embryo selection: a meta-analysis | 31.7 | 0 | 2 |
| Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support | 31.7 | 0 | 2 |
| Delayed intracytoplasmic sperm injection (ICSI) with trophectoderm biopsy and preimplantation genetic screening (PGS) show increased aneuploidy rates but can lead to live births with single thawed euploid embryo transfer (STEET). | 31.7 | 0 | 2 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 31.7 | 0 | 2 |
| A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Performing the embryo transfer: a guideline | 31.7 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 31.7 | 0 | 2 |
| Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles | 31.7 | 0 | 2 |
| Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | 31.7 | 0 | 2 |
| Obstetric and perinatal complications in an oocyte donation programme. Is it time to limit the number of embryos to transfer? | 31.7 | 0 | 2 |
| Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients. | 31.7 | 0 | 2 |
| Oocyte donation--implications for fertility treatment in the nineties. | 31.7 | 0 | 2 |
| Strategy for the prevention of transfusion-transmitted hepatitis--current state of blood donor screening test | 31.7 | 0 | 2 |
| Endometrial preparation: lessons from oocyte donation | 31.7 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 31.7 | 0 | 2 |
| Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial. | 31.7 | 0 | 2 |
| Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. | 31.7 | 0 | 2 |
| Comparison of frozen embryo transfer outcomes at blastocyst stage according to freezing method and type of endometrial preparation | 31.7 | 0 | 2 |
| The yield of universal antibody to hepatitis B core antigen donor screening in theNetherlands, a hepatitis B virus low‐endemic country | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| Prognosis of oocyte donation cycles: a prospective comparison of the in vitro fertilization-embryo transfer cycles of recipients who used shared oocytes versus those who used altruistic donors | 31.7 | 0 | 2 |
| Egg sharing and egg donation: attitudes of British egg donors and recipients | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts | 31.7 | 0 | 2 |
| Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 31.7 | 0 | 2 |
| Blastocyst euploidy and implantation rates in a young (<35 years) and old (≥35 years) presumed fertile and infertile patient population | 31.7 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 31.7 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 31.7 | 0 | 2 |
| Sonographic evaluation of endometrial preparation with oral estrogen-progesterone substitution before cryogenic embryo transfer | 31.7 | 0 | 2 |
| Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Successful outcome after preimplantation genetic screening and very delayed embryo transfer | 31.7 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 31.7 | 0 | 2 |
| Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| An analysis of the impact of embryo transfer difficulty on live birth rates, using a standardised grading system | 31.7 | 0 | 2 |
| Disparities in reproductive outcomes according to the endometrial preparation protocol in frozen embryo transfer : The risk of early pregnancy loss in frozen embryo transfer cycles | 31.7 | 0 | 2 |
| Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women | 31.7 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 31.7 | 0 | 2 |
| High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer | 31.7 | 0 | 2 |
| Donor Motivations, Associated Risks and Ethical Considerations of Oocyte Donation | 31.7 | 0 | 2 |
| Frozen embryo transfer: a review on the optimal endometrial preparation and timing. | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| Elevated serum estradiol levels in artificial autologous frozen embryo transfer cycles negatively impact ongoing pregnancy and live birth rates | 31.7 | 0 | 2 |
| Re: Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis: Significance of advising women prior to fertility treatment | 31.7 | 0 | 2 |
| Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort | 31.7 | 0 | 2 |
| There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy | 31.7 | 0 | 2 |
| Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 31.7 | 0 | 2 |
| Preimplantation genetic testing: polar bodies, blastomeres, trophectoderm cells, or blastocoelic fluid? | 31.7 | 0 | 2 |
| Live birth rates after IVF are lower with frozen donor eggs, study shows: | 31.7 | 0 | 2 |
| Elective single-embryo transfer in oocyte donation programmes: Should it be the rule? | 31.7 | 0 | 2 |
| Double embryo transfer gives good pregnancy and live birth rates in poor responders with a modest increase in multiple birth rates: results from an observational study | 31.7 | 0 | 2 |
| Blastocyst embryo transfer is the primary determinant for improved outcomes in oocyte donation cycles | 31.7 | 0 | 2 |
| Five years of single embryo transfer with anonymous and non-anonymous oocyte donation | 31.7 | 0 | 2 |
| Elective single embryo transfer yields good delivery rates in oocyte donation. | 31.7 | 0 | 2 |
| Minimal genetic screening for gamete donors | 31.7 | 0 | 2 |
| Guidelines for oocyte donation | 31.7 | 0 | 2 |
| Ultrasound guided embryo transfer significantly improves pregnancy rates in women undergoing oocyte donation | 31.7 | 0 | 2 |
| The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy | 31.7 | 0 | 2 |
| Ethical issues of egg donation | 31.7 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 31.7 | 0 | 2 |
| Spontaneous resolution of ectopic pregnancy in a surrogate after oocyte donation and frozen embryo transfer | 31.7 | 0 | 2 |
| Twin pregnancy following embryo transfer on day 7 of the luteal phase in an oocyte donation programme | 31.7 | 0 | 2 |
| Ethical quandaries around expanded carrier screening in third-party reproduction. | 31.7 | 0 | 2 |
| Controversies in assisted reproduction: oocyte donation. Protocols for egg donation | 31.7 | 0 | 2 |
| Expanded carrier screening: what the reproductive endocrinologist needs to know | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| Oocyte donation to postmenopausal women | 31.7 | 0 | 2 |
| Guidelines for oocyte donation | 31.7 | 0 | 2 |
| Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen | 31.7 | 0 | 2 |
| Artificial endometrial preparation for oocyte donation: the effect of estrogen stimulation on clinical outcome | 31.7 | 0 | 2 |
| Pregnancy following oocyte donation and tubal embryo transfer in patients with premature ovarian failure: report of two cases | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Premarital genetic screening for beta thalassemia carrier status of indexed families using HbA2 electrophoresis | 31.7 | 0 | 2 |
| Multinucleation of a sibling blastomere on day 2 suggests unsuitability for embryo transfer in IVF–preimplantation genetic screening cycles | 31.7 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure | 31.7 | 0 | 2 |
| Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer | 31.7 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 31.7 | 0 | 2 |
| Trans dermal estrogen (oestrogel) for endometrial preparation in freeze embryo transfer cycle: An RCT. | 31.7 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 31.7 | 0 | 2 |
| AIUM practice guideline for ultrasonography in reproductive medicine | 31.7 | 0 | 2 |
| 'Elective single embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances': AGAINST: SET maintains live birth rates and provides unique advantages | 31.7 | 0 | 2 |
| Clinical outcomes of two different endometrial preparation methods for cryopreserved-thawed embryo transfer in patients with a normal menstrual cycle | 31.7 | 0 | 2 |
| Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal | 31.7 | 0 | 2 |
| Legalization of social egg freezing would make oocyte donation management easier | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage | 31.7 | 0 | 2 |
| Oral versus transdermal oestrogen delivery for endometrial preparation before embryo transfer: a prospective, comparative, randomized clinical trial | 31.7 | 0 | 2 |
| Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion | 31.7 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion | 31.7 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 31.7 | 0 | 2 |
| Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates | 31.7 | 0 | 2 |
| Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer | 31.7 | 0 | 2 |
| Administration of GnRH Antagonist to Oocyte Donation Recipients | 31.7 | 0 | 2 |
| Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | 31.7 | 0 | 2 |
| GnRH Agonist at Embryo Transfer: IVF Outcomes | 31.7 | 0 | 2 |
| Endometrial Preparation in Frozen Embryo Transfer Cycles | 31.7 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 31.7 | 0 | 2 |
| A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs | 31.7 | 0 | 2 |
| Preimplantation genetic screening (PGS): a tool to increase live birth rates in couples with unexplained recurrent miscarriage? | 31.7 | 0 | 2 |
| Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) | 31.7 | 0 | 2 |
| Single Embryo Transfer vs. Double Embryo Transfer in an Oocyte Donation Programme | 31.7 | 0 | 2 |
| Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Risk of pre-eclampsia after fresh or frozen embryo transfer in patients undergoing oocyte donation | 31.7 | 0 | 2 |
| Pre-Implantation Genetic Screening in Women Under the Age of 36 Years With Single Embryo Transfer | 31.7 | 0 | 2 |
| Endometrial Gene Expression in Different Protocols of Endometrial Preparation for Embryo Transfer' | 31.7 | 0 | 2 |
| Single Embryo TrAnsfeR of Euploid Embryo | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles | 31.7 | 0 | 2 |
| The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos) | 31.7 | 0 | 2 |
| Serum Progesterone on the Day of Embryo Transfer and Pregnancy Rate. | 31.7 | 0 | 2 |
| Endometrial Preparation for Women Undergoing Embryo Transfer Frozen-Thawed Embryo Transfer With and Without Pretreatment With Gonadotropin Releasing Hormone Agonists. | 31.7 | 0 | 2 |
| Vitamin D Influence on Oocyte Donation | 31.7 | 0 | 2 |
| HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients | 31.7 | 0 | 2 |
| Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles | 31.7 | 0 | 2 |
| Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan | 31.7 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 31.7 | 0 | 2 |
| Oocyte Recipient's Decision in the Number of Embryos to be Transferred | 31.7 | 0 | 2 |
| Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) | 31.7 | 0 | 2 |
| The Effect of Acupuncture on Pregnancy Rates in Women Undergoing in Vitro Fertilization With Preimplantation Genetic Screening | 31.7 | 0 | 2 |
| Cumulative Live Birth Rates in Patients With Repeated Implantation Failure (RIF) Undergoing Preimplantation Genetic Screening (PGS ) | 31.7 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 31.7 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 31.7 | 0 | 2 |
| Sildenafil Citrate in Frozen Embryo Transfer | 31.7 | 0 | 2 |
| Natural Cycle/Progesterone Fortified Protocol for Endometrial Preparation for Frozen/Thawed Embryo Transfer | 31.7 | 0 | 2 |
| HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients | 31.7 | 0 | 2 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 31.7 | 0 | 2 |
| The impact of endometrial preparation on implantation following cryopreserved-thawed-embryo transfer | 31.7 | 0 | 2 |
| Hormonal therapy for the synchronization between donor and recipient in an oocyte donation and surrogacy fertilization in vitro-embryo transfer program | 31.7 | 0 | 2 |
| Repetitive oocyte donation | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 31.7 | 0 | 2 |
| Artificial versus stimulated cycles for endometrial preparation prior to frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Appendix A: minimal genetic screening for gamete donors | 31.7 | 0 | 2 |
| Repetitive oocyte donation | 31.7 | 0 | 2 |
| Embryo splitting for infertility treatment | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| Preimplantation genetic screening will play a dominant role in selecting embryos for single embryo transfer | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Preimplantation genetic testing: a Practice Committee opinion | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: a committee opinion | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Endometrial preparation for frozen-thawed embryo transfer in an artificial cycle: transdermal versus vaginal estrogen | 31.7 | 0 | 2 |
| AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan | 31.7 | 0 | 2 |
| Clinical effect of letrozole on the ovulation induction in endometrial preparation for frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Genetic screening in the American Society for Reproductive Medicine's new guidelines on diagnostic evaluation of the infertile male | 31.7 | 0 | 2 |
| Serum Progesterone on the Day of Thawed Embryo Transfer and Pregnancy Rate After an Artificial Endometrial Preparation | 31.7 | 0 | 2 |
| Letrozole ovulation induction: an effective option in endometrial preparation for frozen–thawed embryo transfer | 31.7 | 0 | 2 |
| Psychosocial factors in reproductive medicine | 31.7 | 0 | 2 |
| Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study | 31.7 | 0 | 2 |
| Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome | 31.7 | 0 | 2 |
| Progress of improving blood donor screening by nucleic acid technology | 31.7 | 0 | 2 |
| The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion | 31.7 | 0 | 2 |
| Next generation sequencing for preimplantation genetic screening improves pregnancy outcomes compared with array comparative genomic hybridization in single thawed euploid embryo transfer cycles | 31.7 | 0 | 2 |
| Modified hMG stimulated: an effective option in endometrial preparation for frozen-thawed embryo transfer in patients with normal menstrual cycles | 31.7 | 0 | 2 |
| ASRM standard embryo transfer protocol template: a committee opinion | 31.7 | 0 | 2 |
| Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes | 31.7 | 0 | 2 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 31.7 | 0 | 2 |
| Frozen embryo transfer: evidence-based markers for successful endometrial preparation | 31.7 | 0 | 2 |
| Single and double embryo transfer provide similar live birth rates in frozen cycles | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| Comparison of stimulated versus modified natural cycles for endometrial preparation prior to frozen embryo transfer: a randomized controlled trial | 31.7 | 0 | 2 |
| Androgenicity and fertility treatment in women with unexplained infertility | 31.7 | 0 | 2 |
| A Comparison of Pregnancy Outcomes in Patients Undergoing Donor Egg Single Embryo Transfers With and Without Preimplantation Genetic Testing | 31.7 | 0 | 2 |
| Legal Considerations in Genetic Screening and Testing: Three Case Studies: ACOG Committee Opinion Summary, Number 805 | 31.7 | 0 | 2 |
| Legal Considerations in Genetic Screening and Testing: Three Case Studies: ACOG Committee Opinion, Number 805 | 31.7 | 0 | 2 |
| Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates | 31.7 | 0 | 2 |
| Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer | 31.7 | 0 | 2 |
| Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| Effect of embryo transfer difficulty on live birth rates studied in vitrified-warmed euploid blastocyst transfers | 31.7 | 0 | 2 |
| Live birth rates and perinatal outcomes when all embryos are frozen compared with conventional fresh and frozen embryo transfer: a cohort study of 337,148 in vitro fertilisation cycles | 31.7 | 0 | 2 |
| Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial | 31.7 | 0 | 2 |
| Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology | 31.7 | 0 | 2 |
| Reply: The transnational fresh oocyte donation. Should it be the first choice when implementing an egg donation program in countries with low availability of donors? | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| Corrigendum. Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality | 31.7 | 0 | 2 |
| [Progesterone and frozen-thawed embryo transfer after hormonal replacement therapy for endometrial preparation: An update on medical practices] | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure | 31.7 | 0 | 2 |
| Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study | 31.7 | 0 | 2 |
| Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population | 31.7 | 0 | 2 |
| Black recipients of oocyte donation experience lower live birth rates compared with White recipients | 31.7 | 0 | 2 |
| Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus | 31.7 | 0 | 2 |
| Measuring serum estradiol and progesterone one day prior to frozen embryo transfer improves live birth rates | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| [Cumulative live birth rates after frozen embryo transfer and fresh embryo transfer with oocyte numbers more than 15] | 31.7 | 0 | 2 |
| Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Could fertility clinics offer a sizable improvement of live birth rates by maturing post-GVBD oocytes in vitro? | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Laser irradiation pretreatment improves endometrial preparation of frozen-thawed embryo transfer in recurrent implantation failure patients | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure | 31.7 | 0 | 2 |
| Endometrial preparation for third-party parenting and cryopreserved embryo transfer | 31.7 | 0 | 2 |
| Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality | 31.7 | 0 | 2 |
| Frozen embryo transfer: Endometrial preparation by letrozole versus hormone replacement cycle: A randomized clinical trial | 31.7 | 0 | 2 |
| Cleavage Stage versus Blastocyst Stage Embryo Transfer in Oocyte Donation Cycles | 31.7 | 0 | 2 |
| Single or double embryo transfer? Decision-making process in patients participating in an oocyte donation program | 31.7 | 0 | 2 |
| Spontaneous Conception during In Vitro Fertilization prior to Embryo Transfer without the Opportunity for Preimplantation Genetic Testing | 31.7 | 0 | 2 |
| Endometrial volume measured on the day of embryo transfer is not associated with live birth rates in IVF: a prospective study and review of the literature | 31.7 | 0 | 2 |
| Genetic screening of in vitro fertilization (IVF)-embryo transfer (ET) patients | 31.7 | 0 | 2 |
| Live birth after frozen-thawed embryo transfer: which endometrial preparation protocol is better? | 31.7 | 0 | 2 |
| [Various approaches of endometrial preparation for frozen-thawed embryo transfer] | 31.7 | 0 | 2 |
| Low progesterone levels on the day before natural cycle frozen embryo transfer are negatively associated with live birth rates | 31.7 | 0 | 2 |
| Repetitive oocyte donation: a committee opinion | 31.7 | 0 | 2 |
| Serum progesterone level and ongoing pregnancy rate following frozen-thawed embryo transfer after artificial endometrial preparation: a monocentric retrospective study | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Endometrial preparation using gonadotropin-releasing hormone agonist prior to frozen-thawed embryo transfer in women with repeated implantation failure: An RCT | 31.7 | 0 | 2 |
| Customized Frozen Embryo Transfer after Identification of the Receptivity Window with a Transcriptomic Approach Improves the Implantation and Live Birth Rates in Patients with Repeated Implantation Failure | 31.7 | 0 | 2 |
| Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer? | 31.7 | 0 | 2 |
| Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion | 31.7 | 0 | 2 |
| A clinical and basic study of optimal endometrial preparation protocols for patients with infertility undergoing frozen-thawed embryo transfer | 31.7 | 0 | 2 |
| Use of a male antioxidant nutraceutical is associated with superior live birth rates during IVF treatment | 31.7 | 0 | 2 |
| Reduced live birth rates in frozen versus fresh single cleavage stage embryo transfer cycles: A cross -sectional study | 31.7 | 0 | 2 |
| Effect of uterine dimensions on live birth rates after single embryo transfer in infertile women | 31.7 | 0 | 2 |
| Corrigendum to ``Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial" [Reproductive BioMedicine Online, Volume 38, Issue 3, March 2019, Pages 387-396] | 31.7 | 0 | 2 |
| Ng Soon Chye | 31.7 | 0 | 2 |
| Is pretreatment with GnRH agonist necessary for endometrial preparation for frozen embryo transfer cycles in women with polycystic ovary syndrome? | 31.7 | 0 | 2 |
| Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study | 31.7 | 0 | 2 |
| Reproductive Endocrinology Infertility (REI) Specialists' Utilization and Attitudes Toward Expanded Carrier Screening (ECS) for Third-Party Oocyte Donors | 31.7 | 0 | 2 |
| Hormone Replacement Versus Natural Cycle Protocols of Endometrial Preparation for Frozen Embryo Transfer | 31.7 | 0 | 2 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database | 31.7 | 0 | 2 |
| Day-5 fresh embryo transfer is associated with superior clinical outcomes in oocyte donation cycles compared with day-3 embryo transfer | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course | 31.7 | 0 | 2 |
| Legal considerations in reproductive medicine | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| Women utilizing oocyte donation have a decreased live birth rate if they displayed a low progesterone level in a previous hormonal replacement mock cycle | 31.7 | 0 | 2 |
| Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation. | 31.7 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| Hysteroscopy With Fundus Uterus Scratching Incision VS Office Hysteroscopy Before ET With Donor Eggs | 31.7 | 0 | 2 |
| Effect of Embryo Migration in Fresh Oocyte Donation Cycles | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes | 31.7 | 0 | 2 |
| P–087 Paternal age clinical effect on cumulative live birth rates (CLBR) per inseminated oocyte, embryo transfer and embryo transferred in autologous IVF-ICSI cycles of infertile males | 31.7 | 0 | 2 |
| Comparison of live birth rates after IVF–embryo transfer with and without preimplantation genetic testing for aneuploidies | 31.7 | 0 | 2 |
| Assisted Hatching of the Zona Pellucida Prior to Embryo Transfer in Fresh Donor Egg IVF Cycles | 31.7 | 0 | 2 |
| Recentering Labor in the Egg Donation Bioeconomy: Egg Donors’ (Re)productive Work and Subjectification in Spain | 31.7 | 0 | 2 |
| Choice of fresh homologous or fresh donor embryo transfer is determined primarily by availability of insurance-mandated in vitro fertilization (IVF) coverage and university versus private practice. | 31.7 | 0 | 2 |
| Endometrial Preparation for Frozen-Thawed Embryo Transfer With or Without Pre-Treatment With Gonadotropin Releasing Hormone Agonist | 31.7 | 0 | 2 |
| Application and Challenge of Preimplantation Genetic Testing in Reproductive Medicine | 31.7 | 0 | 2 |
| Endometriosis does not impact live birth rates in frozen embryo transfer (FET) of euploid blastocysts | 31.7 | 0 | 2 |
| Impact of endometrial preparation in cryopreserved-warmed embryo transfer (FET) cycles on perinatal outcome | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy (PGT-A) reduces miscarriage and improves live birth rates in recurrent pregnancy loss patients | 31.7 | 0 | 2 |
| Blastocyst morphology correlates with preimplantation genetic testing for aneuploidy (PGT-A) results and may further predict pregnancy potential after euploid single embryo transfer (SET) | 31.7 | 0 | 2 |
| Time lapse selected elective single embryo transfer in hyaluronon enriched transfer medium in pcos improves live birth rates compared to use of conventional embryo transfer media. a possible alternative to freeze-all cycles in PCOS | 31.7 | 0 | 2 |
| Does massage therapy immediately prior to embryo transfer improve clinical pregnancy rate in IVF-PGT-A (in-vitro fertilization-preimplantation genetic testing for aneuploidy) cycles? | 31.7 | 0 | 2 |
| Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a sart-cors study | 31.7 | 0 | 2 |
| Preimplantation genetic testing (PGT) and frozen embryo transfer (FET) synergistically decrease pre-term delivery in patients undergoing in vitro fertilization (IVF) | 31.7 | 0 | 2 |
| IMPACT OF EXPANDED CARRIER SCREENING (ECS) ON UPTAKE OF PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) | 31.7 | 0 | 2 |
| 8. COMPARISON OF NATURAL CYCLES VERSUS HORMONE REPLACEMENT TREATMENT FOR 2398 FROZEN–THAWED EMBRYO TRANSFER CYCLES FOR PREIMPLANTATION GENETIC TESTING PATIENTS | 31.7 | 0 | 2 |
| Endometrial Preparation for Frozen Embryo Transfer by Supplemented Natural Cycle versus Hormone Replacement Cycle in Regularly Cycling Women | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy: a pragmatic, multicenter randomized clinical trial of single frozen euploid embryo transfer versus selection by morphology alone | 31.7 | 0 | 2 |
| A New Cost-efficient Single Nucleotide Polymorphism (SNP) Preimplantation Genetic TESTING (PGT) Assay for Beta-thalassaemia and simultaneous use with Preimplantation Genetic Screening (PGS) | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| Perceptions of reproductive healthcare providers regarding their involvement in offering expanded carrier screening in fertility clinics: a qualitative study | 31.7 | 0 | 2 |
| Does embryo biopsy, independent of vitrification, impact perinatal outcomes? An analysis of perinatal outcomes following preimplantation genetic testing biopsy in fresh and frozen embryo transfer cycles | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| Singletons birthweight after frozen-thawed embryo transfer is increased after endometrial preparation with artificial cycle compared to mild gonadotropin ovarian stimulation | 31.7 | 0 | 2 |
| Impact of serum progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles on the ongoing pregnancy rate. An interim analysis | 31.7 | 0 | 2 |
| Client experience and use of expanded carrier screening results as part of the semen donor selection process | 31.7 | 0 | 2 |
| In freeze all embryos (FAE) cycles due to endometrial fluid (EF), live birth rates in subsequent frozen embryo transfer (FET) are comparable to those of controls, despite high rates of EF recurrence and cycle cancellation | 31.7 | 0 | 2 |
| Initial serum human chorionic gonadotropin levels predict live birth outcomes following frozen embryo transfer with and without preimplantation genetic testing for aneuploidy (PGT-A) | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 31.7 | 0 | 2 |
| Let ‘Pregnant Women Choose the Destiny for Themselves and Their Child’. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain | 31.7 | 0 | 2 |
| GYN-FIV a.s. | 31.7 | 0 | 2 |
| Time | 25.8 | 1 | 0 |
| Time Person of the Year | 25.8 | 1 | 0 |
| United States Centers for Disease Control and Prevention | 25.8 | 1 | 0 |
| Johns Hopkins School of Medicine | 25.8 | 1 | 0 |
| Pennsylvania Hospital | 25.8 | 1 | 0 |
| Johns Hopkins Hospital | 25.8 | 1 | 0 |
| Human Fertilisation and Embryology Authority | 25.8 | 1 | 0 |
| polymyalgia rheumatica | 25.8 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 25.8 | 1 | 0 |
| UCLA Ronald Reagan Medical Center | 25.8 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 25.8 | 1 | 0 |
| Baylor College of Medicine | 25.8 | 1 | 0 |
| Brigham and Women's Hospital | 25.8 | 1 | 0 |
| National Center for Health Statistics | 25.8 | 1 | 0 |
| Weill Cornell Medicine | 25.8 | 1 | 0 |
| Advisory Committee on Immunization Practices | 25.8 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 25.8 | 1 | 0 |
| Anne Schuchat | 25.8 | 1 | 0 |
| Conceive | 25.8 | 1 | 0 |
| Cooper University Hospital | 25.8 | 1 | 0 |
| Emerging Infectious Diseases | 25.8 | 1 | 0 |
| Epi Map | 25.8 | 1 | 0 |
| Epidemic Intelligence Service | 25.8 | 1 | 0 |
| Fire Fighter Fatality Investigation and Prevention Program | 25.8 | 1 | 0 |
| Genetics and IVF Institute | 25.8 | 1 | 0 |
| Health Hazard Evaluation | 25.8 | 1 | 0 |
| Highland Hospital | 25.8 | 1 | 0 |
| Hospital of the University of Pennsylvania | 25.8 | 1 | 0 |
| Howard County General Hospital | 25.8 | 1 | 0 |
| Jeff Stein | 25.8 | 1 | 0 |
| UCLA Jules Stein Eye Institute | 25.8 | 1 | 0 |
| Lucile Packard Children's Hospital | 25.8 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 25.8 | 1 | 0 |
| Mayo School of Health Sciences | 25.8 | 1 | 0 |
| NYU Langone Health | 25.8 | 1 | 0 |
| National Center for Injury Prevention and Control | 25.8 | 1 | 0 |
| National Diabetes Education Program | 25.8 | 1 | 0 |
| National Health Interview Survey | 25.8 | 1 | 0 |
| Nicholas H Noyes Memorial Hospital | 25.8 | 1 | 0 |
| Penn Presbyterian Medical Center | 25.8 | 1 | 0 |
| Perelman Center for Advanced Medicine | 25.8 | 1 | 0 |
| Public Health Information Network | 25.8 | 1 | 0 |
| Rainbow Babies & Children's Hospital | 25.8 | 1 | 0 |
| Scheie Eye Institute | 25.8 | 1 | 0 |
| Sibley Memorial Hospital | 25.8 | 1 | 0 |
| Q7541087 | 25.8 | 1 | 0 |
| Strong Memorial Hospital | 25.8 | 1 | 0 |
| UCLA Santa Monica Medical Center | 25.8 | 1 | 0 |
| University Hospitals Ahuja Medical Center | 25.8 | 1 | 0 |
| University Hospitals of Cleveland | 25.8 | 1 | 0 |
| University of Chicago Comprehensive Cancer Center | 25.8 | 1 | 0 |
| UChicago Medicine | 25.8 | 1 | 0 |
| University of Pennsylvania Health System | 25.8 | 1 | 0 |
| University of Rochester Medical Center | 25.8 | 1 | 0 |
| VERB | 25.8 | 1 | 0 |
| Vaccines for Children Program | 25.8 | 1 | 0 |
| Victor Velculescu | 25.8 | 1 | 0 |
| NIOSH World Trade Center Health Program | 25.8 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 25.8 | 1 | 0 |
| Theodore H. Schwartz | 25.8 | 1 | 0 |
| National Death Index | 25.8 | 1 | 0 |
| National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention | 25.8 | 1 | 0 |
| Suburban Hospital | 25.8 | 1 | 0 |
| National Center for Immunization and Respiratory Diseases | 25.8 | 1 | 0 |
| The Thriving Cult of Greed and Power | 25.8 | 1 | 0 |
| Margaret Goodell | 25.8 | 1 | 0 |
| Edward Thomas Ryan | 25.8 | 1 | 0 |
| NIOSH pocket guide to chemical hazards (superseded) | 25.8 | 1 | 0 |
| William G. Nelson | 25.8 | 1 | 0 |
| Charles Limb | 25.8 | 1 | 0 |
| National Violent Death Reporting System | 25.8 | 1 | 0 |
| Sonja A. Rasmussen | 25.8 | 1 | 0 |
| Mayo Clinic Graduate School of Biomedical Sciences | 25.8 | 1 | 0 |
| Monthly vital statistics report : provisional statistics from the National Center for Health Statistics | 25.8 | 1 | 0 |
| Advance data | 25.8 | 1 | 0 |
| Vital and health statistics. Series 10, Data from the National Health Survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 11, Data from the national health survey | 25.8 | 1 | 0 |
| Vital and health statistics. Series 21, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| Vital and health statistics. Series 23, Data from the National Survey of Family Growth | 25.8 | 1 | 0 |
| Vital and health statistics. Series 20, Data from the National Vital Statistics System | 25.8 | 1 | 0 |
| National health statistics reports | 25.8 | 1 | 0 |
| Case orthopaedic journal | 25.8 | 1 | 0 |
| London Women's Clinic | 25.8 | 1 | 0 |
| Sidney Kimmel Comprehensive Cancer Center | 25.8 | 1 | 0 |
| Office of Public Health Genomics | 25.8 | 1 | 0 |
| Hartmut Land | 25.8 | 1 | 0 |
| University Hospitals Geneva Medical Center | 25.8 | 1 | 0 |
| Office of Public Health Preparedness and Response | 25.8 | 1 | 0 |
| Office for State, Tribal, Local and Territorial Support | 25.8 | 1 | 0 |
| Center for Global Health | 25.8 | 1 | 0 |
| Mayo Clinic Hospital | 25.8 | 1 | 0 |
| San Juan Quarantine Station | 25.8 | 1 | 0 |
| University Hospitals Seidman Cancer Center | 25.8 | 1 | 0 |
| Instituto Bernabeu | 25.8 | 1 | 0 |
| Boston IVF | 25.8 | 1 | 0 |
| Igenomix | 25.8 | 1 | 0 |
| Reproductive Science Center | 25.8 | 1 | 0 |
| Mattel Children's Hospital | 25.8 | 1 | 0 |
| National Center for Environmental Health | 25.8 | 1 | 0 |
| Center for Human Reproduction | 25.8 | 1 | 0 |
| Harvard Affiliated Emergency Medicine Residency | 25.8 | 1 | 0 |
| Reproductive Genetics Institute | 25.8 | 1 | 0 |
| National Center for Infectious Diseases | 25.8 | 1 | 0 |
| Golisano Children's Hospital | 25.8 | 1 | 0 |
| National Center on Birth Defects and Developmental Disabilities | 25.8 | 1 | 0 |
| Division of Regulatory Science and Compliance | 25.8 | 1 | 0 |
| Buck S. Samuel | 25.8 | 1 | 0 |
| Office of Infectious Diseases | 25.8 | 1 | 0 |
| Center for Surveillance, Epidemiology, and Laboratory Services | 25.8 | 1 | 0 |
| Office of Minority Health and Health Equity | 25.8 | 1 | 0 |
| Mayo Clinic Scottsdale | 25.8 | 1 | 0 |
| Systems Biology in Reproductive Medicine | 20.0 | 0 | 1 |
| Robert Edwards | 20.0 | 0 | 1 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| genetic testing | 20.0 | 0 | 1 |
| reproductive medicine | 20.0 | 0 | 1 |
| Q847465 | 20.0 | 0 | 1 |
| Dor Yeshorim | 20.0 | 0 | 1 |
| Creighton Model FertilityCare System | 20.0 | 0 | 1 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| genetic screen | 20.0 | 0 | 1 |
| Center for Reproductive Medicine | 20.0 | 0 | 1 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| fertility tourism | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |
| Newborn Screening Saves Lives Act of 2007 | 20.0 | 0 | 1 |
| Reproductive endocrinology | 20.0 | 0 | 1 |
| reproductive surgery | 20.0 | 0 | 1 |
| semen collection | 20.0 | 0 | 1 |
| Slovenian fertility treatment referendum, 2001 | 20.0 | 0 | 1 |
| Category:A-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:B-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:C-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FL-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:GA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:High-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Low-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Mid-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by importance | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by quality | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force articles | 20.0 | 0 | 1 |
| Category:NA-Class reproductive medicine pages | 20.0 | 0 | 1 |
| Category:NA-importance reproductive medicine pages | 20.0 | 0 | 1 |
| Category:Start-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Stub-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Top-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unassessed reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unknown-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:List-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Seminars in Reproductive Medicine | 20.0 | 0 | 1 |
| Molecular Human Reproduction | 20.0 | 0 | 1 |
| Journal of Reproductive Medicine | 20.0 | 0 | 1 |
| Obstetrics, Gynaecology and Reproductive Medicine | 20.0 | 0 | 1 |
| Anna Glasier | 20.0 | 0 | 1 |
| carrier testing | 20.0 | 0 | 1 |
| reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| Rest on the Flight into Egypt | 20.0 | 0 | 1 |
| Harbor at Honfleur | 20.0 | 0 | 1 |
| Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study | 20.0 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 20.0 | 0 | 1 |
| Reproductive medicine in northwest Argentina: traditional and institutional systems | 20.0 | 0 | 1 |
| Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS) | 20.0 | 0 | 1 |
| Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention | 20.0 | 0 | 1 |
| WikiProject Reproductive medicine | 20.0 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 20.0 | 0 | 1 |
| donor selection | 20.0 | 0 | 1 |
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | 20.0 | 0 | 1 |
| An historical look at embryo transfer | 20.0 | 0 | 1 |
| Scientific and ethical aspects of genetic screening of workers for cancer risk: The case of the n-acetyltransferase phenotype | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 20.0 | 0 | 1 |
| Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease | 20.0 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| In memoriam: Celso-Ramon Garcia, M.D. (1922-2004), reproductive medicine visionary | 20.0 | 0 | 1 |
| Legal considerations of clinical guidelines: will NICE make a difference? | 20.0 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 20.0 | 0 | 1 |
| Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease | 20.0 | 0 | 1 |
| Carrier screening in individuals of Ashkenazi Jewish descent | 20.0 | 0 | 1 |
| Reverse genetic screening identifies five E-class PPR proteins involved in RNA editing in mitochondria of Arabidopsis thaliana | 20.0 | 0 | 1 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 20.0 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 20.0 | 0 | 1 |
| A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening | 20.0 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 20.0 | 0 | 1 |
| Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria | 20.0 | 0 | 1 |
| Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening | 20.0 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 20.0 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 20.0 | 0 | 1 |
| The minisequencing method: a simple strategy for genetic screening of MEN 2 families | 20.0 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 20.0 | 0 | 1 |
| A focused and efficient genetic screening strategy in the mouse: identification of mutations that disrupt cortical development | 20.0 | 0 | 1 |
| The stork and the syringe: a political history of reproductive medicine | 20.0 | 0 | 1 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 20.0 | 0 | 1 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 20.0 | 0 | 1 |
| Clarifying the role of three-dimensional transvaginal sonography in reproductive medicine: an evidenced-based appraisal | 20.0 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 20.0 | 0 | 1 |
| Engineering a rare-cutting restriction enzyme: genetic screening and selection of NotI variants | 20.0 | 0 | 1 |
| Category:Medicine/Reproductive medicine task force articles needing expert attention | 20.0 | 0 | 1 |
| Evaluation of mine electrical systems with respect to safety, technology, economics, and legal considerations - 2 volume set. Volume 2 - appendices | 20.0 | 0 | 1 |
| Evaluation of Mine Electrical Systems With Respect to Safety, Technology, Economics and Legal Considerations | 20.0 | 0 | 1 |
| Evaluation of mine electrical systems with respect to safety, technology, economics, and legal considerations | 20.0 | 0 | 1 |
| Evaluation of mine electrical systems with respect to safety, technology, economics, and legal considerations - 2 volume set. Volume 1 - text, tables and analyses | 20.0 | 0 | 1 |
| Genetic screening and monitoring for workers | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 20.0 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 20.0 | 0 | 1 |
| Maternal and fetal outcomes in oocyte donation pregnancies | 20.0 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 20.0 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 20.0 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 20.0 | 0 | 1 |
| Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine | 20.0 | 0 | 1 |
| Expanded carrier screening: A review of early implementation and literature | 20.0 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 20.0 | 0 | 1 |
| Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens | 20.0 | 0 | 1 |
| Bibliometric mapping and clustering analysis of Iranian papers on reproductive medicine in Scopus database (2010-2014) | 20.0 | 0 | 1 |
| Stem cells in reproductive medicine: ready for the patient? | 20.0 | 0 | 1 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 20.0 | 0 | 1 |
| New advances of preimplantation and prenatal genetic screening and noninvasive testing as a potential predictor of health status of babies | 20.0 | 0 | 1 |
| Psychological Screening/Phenotyping as Predictors for Spinal Cord Stimulation | 20.0 | 0 | 1 |
| The presence, role and clinical use of spermatozoal RNAs | 20.0 | 0 | 1 |
| Genetic screening for the risk of type 2 diabetes: worthless or valuable? | 20.0 | 0 | 1 |
| Infertility and reproductive medicine clinics of North America | 20.0 | 0 | 1 |
| Iranian journal of reproductive medicine Yazd Research & Clinical Centre for Infertility | 20.0 | 0 | 1 |
| Clinical and experimental reproductive medicine | 20.0 | 0 | 1 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss | 20.0 | 0 | 1 |
| Reproduction and Breast Cancer Risk | 20.0 | 0 | 1 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 20.0 | 0 | 1 |
| Approach to caring for developmentally disabled adults in the community: medical, ethical, and legal considerations | 20.0 | 0 | 1 |
| Influence of anti-HBc positive organ donor in lung donor selection | 20.0 | 0 | 1 |
| Lung donor selection criteria | 20.0 | 0 | 1 |
| BRCAGenetic Screening in Middle Eastern and North African: Mutational Spectrum and FounderBRCA1Mutation (c.798_799delTT) in North African | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 20.0 | 0 | 1 |
| Optimal pig donor selection in islet xenotransplantation: current status and future perspectives | 20.0 | 0 | 1 |
| Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? | 20.0 | 0 | 1 |
| “Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening | 20.0 | 0 | 1 |
| A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network | 20.0 | 0 | 1 |
| Mary Barton | 20.0 | 0 | 1 |
| PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review | 20.0 | 0 | 1 |
| Journal of in vitro fertilization and embryo transfer : IVF | 20.0 | 0 | 1 |
| Seminars in reproductive endocrinology | 20.0 | 0 | 1 |
| Annual progress in reproductive medicine | 20.0 | 0 | 1 |
| International journal of reproductive medicine | 20.0 | 0 | 1 |
| International journal of gynecological obstetrical and reproductive medicine research | 20.0 | 0 | 1 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 20.0 | 0 | 1 |
| Recent advances in prenatal genetic screening and testing | 20.0 | 0 | 1 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 20.0 | 0 | 1 |
| Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review | 20.0 | 0 | 1 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 20.0 | 0 | 1 |
| Granulocyte colony-stimulating factor and reproductive medicine: A review | 20.0 | 0 | 1 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 20.0 | 0 | 1 |
| Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine | 20.0 | 0 | 1 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 20.0 | 0 | 1 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 20.0 | 0 | 1 |
| Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate | 20.0 | 0 | 1 |
| Birth after the reimplantation of a human embryo | 20.0 | 0 | 1 |
| Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens | 20.0 | 0 | 1 |
| Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety | 20.0 | 0 | 1 |
| Transplantation in reproductive medicine: previous experience, present knowledge and future prospects | 20.0 | 0 | 1 |
| Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure | 20.0 | 0 | 1 |
| Listing of common HLA alleles and haplotypes based on the study of 356 families residing in the Paris, France, area: implications for unrelated hematopoietic stem cell donor selection | 20.0 | 0 | 1 |
| The use of donor eggs and embryos in the management of human infertility | 20.0 | 0 | 1 |
| Genetic screening in the workplace: ethical issues | 20.0 | 0 | 1 |
| Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series | 20.0 | 0 | 1 |
| Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy | 20.0 | 0 | 1 |
| Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges | 20.0 | 0 | 1 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Carrier screening for spinal muscular atrophy | 20.0 | 0 | 1 |
| Raman microspectroscopy: shining a new light on reproductive medicine | 20.0 | 0 | 1 |
| Births after transfer of zona-free blastocysts in oocyte donation cycles | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 20.0 | 0 | 1 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial | 20.0 | 0 | 1 |
| Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment | 20.0 | 0 | 1 |
| Paternal Urinary Concentrations of Parabens and Other Phenols in Relation to Reproductive Outcomes among Couples from a Fertility Clinic | 20.0 | 0 | 1 |
| Bergen Shopping Addiction Scale | 20.0 | 0 | 1 |
| Preimplantation genetic screening | 20.0 | 0 | 1 |
| Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center | 20.0 | 0 | 1 |
| Forward genetic screening for the improved production of fermentable sugars from plant biomass | 20.0 | 0 | 1 |
| Biomarkers in reproductive medicine: the promise, and can it be fulfilled? | 20.0 | 0 | 1 |
| Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies | 20.0 | 0 | 1 |
| Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation | 20.0 | 0 | 1 |
| Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases | 20.0 | 0 | 1 |
| Congenital Malformations among Babies Born Following Letrozole or Clomiphene for Infertility Treatment | 20.0 | 0 | 1 |
| Three Giants in the Cradle of Reproductive Medicine; Reproduction Theories of the Seventeenth Century as Discerned by Pregnancy Portraiture in the Oeuvre of Jan Vermeer | 20.0 | 0 | 1 |
| Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials | 20.0 | 0 | 1 |
| Roger Gosden | 20.0 | 0 | 1 |
| Approaches to prenatal cystic fibrosis carrier screening | 20.0 | 0 | 1 |
| The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: A randomized clinical trial | 20.0 | 0 | 1 |
| A Chemical Genetic Screening Procedure for Arabidopsis thaliana Seedlings | 20.0 | 0 | 1 |
| Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos | 20.0 | 0 | 1 |
| The effect of endometrial injury on pregnancy rate in frozen-thawed embryo transfer: A randomized control trial | 20.0 | 0 | 1 |
| Application of human haploid cell genetic screening model in identifying the genes required for resistance to environmental toxicants: Chlorpyrifos as a case study | 20.0 | 0 | 1 |
| Reproductive Endocrinology and Infertility | 20.0 | 0 | 1 |
| GIFT The Hope for Future Infertility Treatment | 20.0 | 0 | 1 |
| Genetic Screening for Prey in the Gut Contents from a Giant Squid (Architeuthis sp.) | 20.0 | 0 | 1 |
| The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent | 20.0 | 0 | 1 |
| Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune | 20.0 | 0 | 1 |
| Blood donor screening for West Nile virus (WNV) revealed acute Usutu virus (USUV) infection, Germany, September 2016 | 20.0 | 0 | 1 |
| William F. Crowley | 20.0 | 0 | 1 |
| Willingness of the local health department workforce to respond to infectious disease events: empirical, ethical, and legal considerations | 20.0 | 0 | 1 |
| Legal considerations during pediatric emergency mass critical care events | 20.0 | 0 | 1 |
| Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review | 20.0 | 0 | 1 |
| Psychopathology and neoplastic disease: medico-social and medico-legal considerations. | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 20.0 | 0 | 1 |
| Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis | 20.0 | 0 | 1 |
| Current and future role of genetic screening in gynecologic malignancies | 20.0 | 0 | 1 |
| Howard and Georgeanna Jones Foundation for Reproductive Medicine | 20.0 | 0 | 1 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 20.0 | 0 | 1 |
| Institute for Reproductive Medicine | 20.0 | 0 | 1 |
| Reproductive Medicine Associates of New Jersey | 20.0 | 0 | 1 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 20.0 | 0 | 1 |
| Reproduction in couples who are affected by human immunodeficiency virus: Medical, ethical, and legal considerations | 20.0 | 0 | 1 |
| Using complementary therapies within nursing: some ethical and legal considerations | 20.0 | 0 | 1 |
| Alternative treatments in reproductive medicine. The vexing problem of 'seemingly impeccable trials...'. | 20.0 | 0 | 1 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 20.0 | 0 | 1 |
| Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes | 20.0 | 0 | 1 |
| Recruitment strategies in two reproductive medicine network infertility trials | 20.0 | 0 | 1 |
| Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Infertile couples' experience of family stress while women are hospitalized for ovarian hyperstimulation syndrome during infertility treatment | 20.0 | 0 | 1 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 20.0 | 0 | 1 |
| Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. | 20.0 | 0 | 1 |
| Distributive justice and infertility treatment in Canada | 20.0 | 0 | 1 |
| Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations | 20.0 | 0 | 1 |
| Sperm or oocyte donation: the dynamics of making the decision regarding the method and timing of disclosure of information to the sibling | 20.0 | 0 | 1 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 20.0 | 0 | 1 |
| Prevention of prematurity by single embryo transfer | 20.0 | 0 | 1 |
| Letrozole versus clomiphene for infertility in the polycystic ovary syndrome | 20.0 | 0 | 1 |
| Regulating (or not) reproductive medicine: an alternative to letting the market decide | 20.0 | 0 | 1 |
| Genetic screening for hypersusceptibles in industry | 20.0 | 0 | 1 |
| Breast cancer genetic screening and critical bioethics' gaze. | 20.0 | 0 | 1 |
| Body mass index and intercourse compliance | 20.0 | 0 | 1 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Inhibin, activin, and follistatin in reproductive medicine | 20.0 | 0 | 1 |
| Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism | 20.0 | 0 | 1 |
| Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial | 20.0 | 0 | 1 |
| Predictors of pregnancy in women with polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial | 20.0 | 0 | 1 |
| Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction | 20.0 | 0 | 1 |
| Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene | 20.0 | 0 | 1 |
| Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome | 20.0 | 0 | 1 |
| Genetic screening in a university clinic: impact of primary language | 20.0 | 0 | 1 |
| Comprehensive genetic screening of KCNQ4 in a large autosomal dominant nonsyndromic hearing loss cohort: genotype-phenotype correlations and a founder mutation. | 20.0 | 0 | 1 |
| Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates | 20.0 | 0 | 1 |
| The glycinergic system in human startle disease: a genetic screening approach | 20.0 | 0 | 1 |
| Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. | 20.0 | 0 | 1 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 20.0 | 0 | 1 |
| Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer | 20.0 | 0 | 1 |
| Comparison of US population and live birth rates with poison exposures reported to the National Poison Data System (NPDS): children ages 0-5 years from 2000 to 2012. | 20.0 | 0 | 1 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 20.0 | 0 | 1 |
| Cultivation of the notochord of a Balanoglossus species in diffusion chambers | 20.0 | 0 | 1 |
| Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set | 20.0 | 0 | 1 |
| Medical genetics in reproductive medicine | 20.0 | 0 | 1 |
| No evidence that embryo selection by near-infrared spectroscopy in addition to morphology is able to improve live birth rates: results from an individual patient data meta-analysis. | 20.0 | 0 | 1 |
| Patient-Health Care Provider Conversations About Prenatal Genetic Screening: Recommendation or Personal Choice | 20.0 | 0 | 1 |
| It ‘did what it said on the tin’ – Participant's views of the content and process of donor conception parenthood preparation workshops | 20.0 | 0 | 1 |
| The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review | 20.0 | 0 | 1 |
| Selection-subtraction approach (SSA): a universal genetic screening technique that enables negative selection | 20.0 | 0 | 1 |
| High-throughput genetic screening using matrix-assisted laser desorption/ionization mass spectrometry | 20.0 | 0 | 1 |
| Data processing and exchange tools to facilitate chemical genetic screening processes | 20.0 | 0 | 1 |
| Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape | 20.0 | 0 | 1 |
| A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells | 20.0 | 0 | 1 |
| The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study | 20.0 | 0 | 1 |
| ["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer]. | 20.0 | 0 | 1 |
| The use of human tissue in epidemiological research; ethical and legal considerations in two biobanks in Belgium | 20.0 | 0 | 1 |
| Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database | 20.0 | 0 | 1 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 20.0 | 0 | 1 |
| Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. | 20.0 | 0 | 1 |
| Public opinion regarding oocyte donation in Turkey: first data from a secular population among the Islamic world. | 20.0 | 0 | 1 |
| Reliability of HLA-Cw data collected in unrelated bone marrow registry and their usefulness for preliminary donor selection. | 20.0 | 0 | 1 |
| West Nile virus infections projected from blood donor screening data, United States, 2003 | 20.0 | 0 | 1 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 20.0 | 0 | 1 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 20.0 | 0 | 1 |
| The German Middleway as Precursor for Single Embryo Transfer. A Retrospective Data-analysis of the Düsseldorf University Hospital's Interdisciplinary Fertility Centre - UniKiD. | 20.0 | 0 | 1 |
| Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation | 20.0 | 0 | 1 |
| IVF with preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees | 20.0 | 0 | 1 |
| Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. | 20.0 | 0 | 1 |
| Ethical and legal considerations regarding disputed authorship with the use of shared data | 20.0 | 0 | 1 |
| Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016 | 20.0 | 0 | 1 |
| Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients | 20.0 | 0 | 1 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 20.0 | 0 | 1 |
| Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred | 20.0 | 0 | 1 |
| Rapid assays for detection of anti-islet autoantibodies: implications for organ donor screening | 20.0 | 0 | 1 |
| Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | 20.0 | 0 | 1 |
| Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations. | 20.0 | 0 | 1 |
| Long QT syndrome in South Africa: the results of comprehensive genetic screening | 20.0 | 0 | 1 |
| Proteomics in reproductive medicine: the technology for separation and identification of proteins | 20.0 | 0 | 1 |
| A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 20.0 | 0 | 1 |
| Triazine-based tyrosinase inhibitors identified by chemical genetic screening | 20.0 | 0 | 1 |
| Australian attitudes to DNA sample banks and genetic screening | 20.0 | 0 | 1 |
| Present state of reproductive medicine in Japan - ethical issues with a focus on those seen in court cases | 20.0 | 0 | 1 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 20.0 | 0 | 1 |
| Applications of microarray in reproductive medicine. | 20.0 | 0 | 1 |
| Pregnancy outcomes after assisted reproductive technology | 20.0 | 0 | 1 |
| A list and analysis of reproductive medicine periodicals indexed in MEDLINE in 2006 | 20.0 | 0 | 1 |
| Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening | 20.0 | 0 | 1 |
| Laser-induced thrombosis in zebrafish larvae: a novel genetic screening method for thrombosis | 20.0 | 0 | 1 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 20.0 | 0 | 1 |
| An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity | 20.0 | 0 | 1 |
| Legal considerations in cosmetic laser surgery | 20.0 | 0 | 1 |
| Effect of passive uterine straightening during embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Identification of novel pigmentation modulators by chemical genetic screening | 20.0 | 0 | 1 |
| Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations | 20.0 | 0 | 1 |
| Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| A comparison of manual therapy and active rehabilitation in the treatment of non specific low back pain with particular reference to a patient's Linton & Hallden psychological screening score: a pilot study | 20.0 | 0 | 1 |
| Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content | 20.0 | 0 | 1 |
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Legal considerations surrounding cosmetic surgery | 20.0 | 0 | 1 |
| A yeast-based genetic screening to identify human proteins that increase homologous recombination | 20.0 | 0 | 1 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 20.0 | 0 | 1 |
| Effect of the size of zona pellucida opening by laser assisted hatching on clinical outcome of frozen cleaved embryos that were cultured to blastocyst after thawing in women with multiple implantation failures of embryo transfer: a retrospective stu | 20.0 | 0 | 1 |
| Impact of assisted hatching on fresh and frozen-thawed embryo transfer cycles: a prospective, randomized study | 20.0 | 0 | 1 |
| Medical-legal considerations in the medical spa environment | 20.0 | 0 | 1 |
| Genetic screening in haemolytic uraemic syndrome | 20.0 | 0 | 1 |
| Flow cytometric phenotyping of platelet HPA-1a antigen: donor screening for a case of neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies. | 20.0 | 0 | 1 |
| Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis | 20.0 | 0 | 1 |
| A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario | 20.0 | 0 | 1 |
| Indications and options for endometrial ablation | 20.0 | 0 | 1 |
| Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester | 20.0 | 0 | 1 |
| Effect of stem cell activation, culture media of manipulated embryos, and site of embryo transfer in the production of F0 embryonic stem cell mice. | 20.0 | 0 | 1 |
| Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine | 20.0 | 0 | 1 |
| Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies | 20.0 | 0 | 1 |
| Clinical photography in dermatology: ethical and medico-legal considerations in the age of digital and smartphone technology. | 20.0 | 0 | 1 |
| Optimizing donor selection in a cord blood bank | 20.0 | 0 | 1 |
| Initial experience with a donor egg bank | 20.0 | 0 | 1 |
| Donor screening for hepatitis B virus infection in a cell and tissue bank | 20.0 | 0 | 1 |
| A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening | 20.0 | 0 | 1 |
| Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types | 20.0 | 0 | 1 |
| Role of lymphocytotoxicity and staph-protein A assays in platelet donor selection. | 20.0 | 0 | 1 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 20.0 | 0 | 1 |
| Blood group genotyping: from patient to high-throughput donor screening | 20.0 | 0 | 1 |
| Incorporating natural variation into IVF clinic league tables: The Expected Rank | 20.0 | 0 | 1 |
| Genetic screening of 104 patients with congenitally malformed hearts revealed a fresh mutation of GATA4 in those with atrial septal defects | 20.0 | 0 | 1 |
| Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients | 20.0 | 0 | 1 |
| Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients | 20.0 | 0 | 1 |
| Chemical genetic screening in the zebrafish embryo | 20.0 | 0 | 1 |
| Preimplantation genetic testing | 20.0 | 0 | 1 |
| Significance of reproductive medicine in regard to judicial and ethical concerns in Germany | 20.0 | 0 | 1 |
| Embryo recovery rate and recipients' pregnancy rate after nonsurgical embryo transfer in donkeys | 20.0 | 0 | 1 |
| Effect of laser zona thinning on vitrified-warmed embryo transfer at the cleavage stage: a prospective, randomized study | 20.0 | 0 | 1 |
| Embryo transfer in rabbits | 20.0 | 0 | 1 |
| Reproductive endocrinology: quo vadis? Scientific, social, ethical and economic challenges. | 20.0 | 0 | 1 |
| Thalassemia carrier screening and prenatal diagnosis among the British Columbia (Canada) population of Chinese descent | 20.0 | 0 | 1 |
| Preparation of endometrium for egg donation | 20.0 | 0 | 1 |
| Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Dairy intake and semen quality among men attending a fertility clinic | 20.0 | 0 | 1 |
| Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing | 20.0 | 0 | 1 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 20.0 | 0 | 1 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 20.0 | 0 | 1 |
| Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes. | 20.0 | 0 | 1 |
| Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance | 20.0 | 0 | 1 |
| Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription. | 20.0 | 0 | 1 |
| Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities | 20.0 | 0 | 1 |
| The State of Reproductive Medicine in Germany | 20.0 | 0 | 1 |
| Should patients with recent onset rheumatoid arthritis be offered genetic screening? | 20.0 | 0 | 1 |
| Should patients with recent onset of rheumatoid arthritis be offered genetic screening? | 20.0 | 0 | 1 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 20.0 | 0 | 1 |
| Assessment of endometrial and ovarian characteristics using three dimensional power Doppler ultrasound to predict response in frozen embryo transfer cycles | 20.0 | 0 | 1 |
| Legal considerations at the end of life | 20.0 | 0 | 1 |
| Elective single embryo transfer following in vitro fertilization | 20.0 | 0 | 1 |
| Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic | 20.0 | 0 | 1 |
| Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer | 20.0 | 0 | 1 |
| Serum progesterone concentration on day of embryo transfer in donor oocyte cycles | 20.0 | 0 | 1 |
| Knowledge and perceptions of haemoglobinopathy carrier screening among general practitioners in Cardiff | 20.0 | 0 | 1 |
| The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing | 20.0 | 0 | 1 |
| Effects of genetic screening on perceptions of health: a pilot study | 20.0 | 0 | 1 |
| Principles and practicalities of carrier screening: attitudes of recent parents | 20.0 | 0 | 1 |
| Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. | 20.0 | 0 | 1 |
| A new approach to prenatal cystic fibrosis carrier screening | 20.0 | 0 | 1 |
| 'Inside-out', back-to-front: a model for clinical population genetic screening | 20.0 | 0 | 1 |
| Pre-implantation genetic screening using fluorescence in situ hybridization in couples of Indian ethnicity: Is there a scope? | 20.0 | 0 | 1 |
| Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT | 20.0 | 0 | 1 |
| The Internet, intranets and reproductive medicine | 20.0 | 0 | 1 |
| What factors are important for successful embryo transfer after in-vitro fertilization? | 20.0 | 0 | 1 |
| Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization | 20.0 | 0 | 1 |
| Molecular pathology and cancer genetic screening. | 20.0 | 0 | 1 |
| The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial | 20.0 | 0 | 1 |
| Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri | 20.0 | 0 | 1 |
| Case management's legal considerations. | 20.0 | 0 | 1 |
| Attitudes of Infertile Couples, Fertility Clinic Staff and Researchers toward Personhood of The Human Embryo in Iran | 20.0 | 0 | 1 |
| The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model | 20.0 | 0 | 1 |
| Is a Blanket Elective Single Embryo Transfer Policy Defensible? | 20.0 | 0 | 1 |
| What next for preimplantation genetic screening? A polar body approach! | 20.0 | 0 | 1 |
| Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States | 20.0 | 0 | 1 |
| Recombinant follitropin alfa/lutropin alfa in fertility treatment. | 20.0 | 0 | 1 |
| Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives | 20.0 | 0 | 1 |
| Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives. | 20.0 | 0 | 1 |
| Promoting the use of elective single embryo transfer in clinical practice | 20.0 | 0 | 1 |
| Successful pregnancy with donor eggs in-vitro fertilization after premature ovarian insufficiency in a tertiary hospital in a low-income setting: a case report | 20.0 | 0 | 1 |
| Heterologous Embryo Transfer: Magisterial Answers and Metaphysical Questions | 20.0 | 0 | 1 |
| A dental approach to carrier screening in X linked hypohidrotic ectodermal dysplasia | 20.0 | 0 | 1 |
| Direct marketing of cystic fibrosis carrier screening: commercial push or population need? | 20.0 | 0 | 1 |
| Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay | 20.0 | 0 | 1 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 20.0 | 0 | 1 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 20.0 | 0 | 1 |
| Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. | 20.0 | 0 | 1 |
| Use of fertility treatment modalities in a large United States cohort of professional women. | 20.0 | 0 | 1 |
| Embryo transfer cannot delineate between the maternal pregnancy environment and germ line effects in the transgenerational transmission of disease in rats | 20.0 | 0 | 1 |
| The role of ovarian volume in reproductive medicine. | 20.0 | 0 | 1 |
| Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: case report | 20.0 | 0 | 1 |
| Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening. | 20.0 | 0 | 1 |
| Tay-Sachs disease carrier screening: a model for prevention of genetic disease | 20.0 | 0 | 1 |
| Screening Jews and genes: a consideration of the ethics of genetic screening within the Jewish community: challenges and responses | 20.0 | 0 | 1 |
| A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles | 20.0 | 0 | 1 |
| Long term costs and effects of reducing the number of twin pregnancies in IVF by single embryo transfer: the TwinSing study | 20.0 | 0 | 1 |
| Reproductive endocrinology of female elasmobranchs: lessons from the little skate (Raja erinacea) and spiny dogfish (Squalus acanthias). | 20.0 | 0 | 1 |
| Laparoscopy vs. laparotomy for embryo transfer to produce transgenic goats (Capra hircus). | 20.0 | 0 | 1 |
| Genetic screening for familial gastric cancer | 20.0 | 0 | 1 |
| We need a prospective varicocelectomy trial | 20.0 | 0 | 1 |
| Frozen embryo transfer prevents the detrimental effect of high estrogen on endometrium receptivity | 20.0 | 0 | 1 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 20.0 | 0 | 1 |
| Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome? | 20.0 | 0 | 1 |
| Factors associated with the use of elective single-embryo transfer and pregnancy outcomes in the United States, 2004-2012. | 20.0 | 0 | 1 |
| Hepatitis C Virus: Unnoticed and on the Rise in Blood Donor Screening? A 5 Years Cross-sectional Study on Seroprevalence in Voluntary Blood Donors from Central India | 20.0 | 0 | 1 |
| Medical legal considerations in temporomandibular disorders | 20.0 | 0 | 1 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 20.0 | 0 | 1 |
| Current status of comprehensive chromosome screening for elective single-embryo transfer. | 20.0 | 0 | 1 |
| Chemical Genetic Screening for Compounds That Preferentially Inhibit Growth of Methylthioadenosine Phosphorylase (MTAP)–Deficient Saccharomyces cerevisiae | 20.0 | 0 | 1 |
| Carrier screening for inherited haemoglobin disorders among secondary school students and young adults in Latium, Italy | 20.0 | 0 | 1 |
| Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases | 20.0 | 0 | 1 |
| Attitudes and opinions of pregnant women who are not offered cystic fibrosis carrier screening. | 20.0 | 0 | 1 |
| Desire for a child and eating disorders in women seeking infertility treatment | 20.0 | 0 | 1 |
| GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis | 20.0 | 0 | 1 |
| Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP | 20.0 | 0 | 1 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 20.0 | 0 | 1 |
| The past, present and future of reproductive endocrinology. | 20.0 | 0 | 1 |
| Gene identification in black cohosh (Actaea racemosa L.): expressed sequence tag profiling and genetic screening yields candidate genes for production of bioactive secondary metabolites | 20.0 | 0 | 1 |
| More collaboration is needed about benefits of new genetic screening tests | 20.0 | 0 | 1 |
| Analysis of Minnesota Multiphasic Personality Inventory-2 profiles of prospective anonymous oocyte donors in relation to the outcome of the donor selection process | 20.0 | 0 | 1 |
| Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening | 20.0 | 0 | 1 |
| Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates | 20.0 | 0 | 1 |
| Fertility treatment in HIV needs multidisciplinary team | 20.0 | 0 | 1 |
| Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin | 20.0 | 0 | 1 |
| Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques | 20.0 | 0 | 1 |
| Genetic screening: A primer for primary care. | 20.0 | 0 | 1 |
| Computing patient data in the cloud: practical and legal considerations for genetics and genomics research in Europe and internationally | 20.0 | 0 | 1 |
| Number of embryos allowed in fertility treatment should be flexible | 20.0 | 0 | 1 |
| Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations. | 20.0 | 0 | 1 |
| Ethical and legal considerations in the provision of nutritional support to the perioperative patient | 20.0 | 0 | 1 |
| Cyclooxygenases in reproductive medicine and biology | 20.0 | 0 | 1 |
| Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytes | 20.0 | 0 | 1 |
| Ethical Issues Currently Being Discussed in Relation to Reproductive Medicine and the Laws Governing Reproductive Medicine | 20.0 | 0 | 1 |
| Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication | 20.0 | 0 | 1 |
| Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease–associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation | 20.0 | 0 | 1 |
| LH-RH analogues: I. Their impact on reproductive medicine | 20.0 | 0 | 1 |
| Comprehensive assessment of serum estradiol impact on selected physiologic markers observed during in-vitro fertilization and embryo transfer cycles. | 20.0 | 0 | 1 |
| The reproductive endocrinology and behavior of Vancouver Island marmot (Marmota vancouverensis). | 20.0 | 0 | 1 |
| Effects of Nursing Care Based on Watson's Theory of Human Caring on Anxiety, Distress, And Coping, When Infertility Treatment Fails: A Randomized Controlled Trial | 20.0 | 0 | 1 |
| Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough? | 20.0 | 0 | 1 |
| Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies | 20.0 | 0 | 1 |
| Prenatal genetic screening: the enigma of selective abortion. | 20.0 | 0 | 1 |
| Impact of egg donation deliveries from domestic and overseas sources on maternal care: a questionnaire survey of Japanese perinatal physicians | 20.0 | 0 | 1 |
| Towards a better understanding of preimplantation genetic screening for aneuploidy: insights from a virtual trial for women under the age of 40 when transferring embryos one at a time | 20.0 | 0 | 1 |
| The prospect for international regulatory interventions in embryo transfer and reproductive technologies in the next century | 20.0 | 0 | 1 |
| State of the art in pig embryo transfer | 20.0 | 0 | 1 |
| The current status of equine embryo transfer | 20.0 | 0 | 1 |
| State of the art in sheep-goat embryo transfer | 20.0 | 0 | 1 |
| Reflections on the golden anniversary of the first embryo transfer to produce a calf | 20.0 | 0 | 1 |
| Enhanced or reduced fetal growth induced by embryo transfer into smaller or larger breeds alters post-natal growth and metabolism in pre-weaning horses | 20.0 | 0 | 1 |
| Women's perceptions and experiences of the challenges in the process of male infertility treatment: A qualitative study. | 20.0 | 0 | 1 |
| Reproductive endocrinology: The emotional cost of contraception | 20.0 | 0 | 1 |
| Whole Genome Amplification of Day 3 or Day 5 Human Embryos Biopsies Provides a Suitable DNA Template for PCR-Based Techniques for Genotyping, a Complement of Preimplantation Genetic Testing. | 20.0 | 0 | 1 |
| Recipient screening in IVF: first data from women undergoing anonymous oocyte donation in Dublin | 20.0 | 0 | 1 |
| Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma | 20.0 | 0 | 1 |
| Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia | 20.0 | 0 | 1 |
| Carrier screening and prenatal diagnosis of beta-thalassemia. | 20.0 | 0 | 1 |
| Two's company, three's a crowd for embryo transfer | 20.0 | 0 | 1 |
| Maternal Effects of Japanese Shorthorn Cows on the Growth of Embryo-transferred Japanese Black Calves in a Cow-calf Grazing System | 20.0 | 0 | 1 |